Pharma, Media, and AI: A New Era

This chapter explores the intricate relationship between the pharmaceutical industry and legacy media, emphasizing the impact of ad spending on media portrayal of health issues. It transitions from historical critiques of media dynamics to contemporary discussions about personal health autonomy and government responses to drug trafficking, before pivoting to advancements in artificial intelligence. Highlighting tools developed by OpenAI, the chapter examines the evolving landscape of research technology, addressing the implications of explainable AI and innovative model selection frameworks.